China's Pharmaceutical Companies Turn Attention to Monoclonal Antibodies

BEIJING, CHINA--Researched by Industrial Info Resources (Sugar Land, Texas)--According to the quarterly financial reports from China's listed pharmaceutical companies, Jiangsu Hengrui Medicine Company Limited has 40 new drugs under development, the most of any Chinese firm, followed by Jiangsu Chia Tai-Tianqing Pharmaceutical Company Limited with 34, and Shanghai Junshi Biosciences Company Limited with 20.